{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:40:13Z","timestamp":1794606013931,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Spanish Ministry of Economy and Innovation","award":["PID2020-113430RB-I00 and 2021-126600OB-I00"],"award-info":[{"award-number":["PID2020-113430RB-I00 and 2021-126600OB-I00"]}]},{"name":"Spanish Ministry of Economy and Innovation","award":["PID2020-113430RB-I00 and 2021-126600OB-I00"],"award-info":[{"award-number":["PID2020-113430RB-I00 and 2021-126600OB-I00"]}]},{"name":"Regional Catalonian Government","award":["2021 SGR 00304"],"award-info":[{"award-number":["2021 SGR 00304"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01756-0","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:36:29Z","timestamp":1747719389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function"],"prefix":"10.1186","volume":"17","author":[{"given":"Iu","family":"Ra\u00efch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Lillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Biel","family":"Rebassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gri\u00f1\u00e1n-Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Bellver-Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Reyes-Resina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Pall\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"1","key":"1756_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols E, Szoeke CEI, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88\u2013106.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1756_CR2","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological Alterations in Alzheimer Disease. Cold Spring Harb Perspect Med. 2011;1(1):a006189\u2013a006189.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1756_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2020.111385","volume":"192","author":"G Abate","year":"2020","unstructured":"Abate G, Vezzoli M, Sandri M, Rungratanawanich W, Memo M, Uberti D. Mitochondria and cellular redox state on the route from ageing to Alzheimer\u2019s disease. Mech Ageing Dev. 2020;192:111385.","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"1756_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/healthcare8030286","volume":"8","author":"G Abate","year":"2020","unstructured":"Abate G, Memo M, Uberti D. Impact of COVID-19 on Alzheimer\u2019s Disease Risk: Viewpoint for Research Action. Healthcare. 2020;8(3):286.","journal-title":"Healthcare"},{"issue":"3","key":"1756_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","volume":"80","author":"G Marsicano","year":"2002","unstructured":"Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem. 2002;80(3):448\u201356.","journal-title":"J Neurochem"},{"key":"1756_CR6","doi-asserted-by":"publisher","unstructured":"Ebell MH, Barry HC, Baduni K, Grasso G. Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis. Ann Fam Med. 2024;22(1):50\u201362. Available from: http:\/\/www.annfammed.org\/lookup\/doi\/https:\/\/doi.org\/10.1370\/afm.3050.","DOI":"10.1370\/afm.3050"},{"key":"1756_CR7","doi-asserted-by":"publisher","unstructured":"Cummings J, Osse AML, Cammann D, Powell J, Chen J. Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer\u2019s Disease. BioDrugs [Internet]. 2024 Jan 13;38(1):5\u201322. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s40259-023-00633-2.","DOI":"10.1007\/s40259-023-00633-2"},{"key":"1756_CR8","doi-asserted-by":"crossref","unstructured":"Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16(1):9\u201329. Available from: https:\/\/www.nature.com\/articles\/s41582-019-0284-z.","DOI":"10.1038\/s41582-019-0284-z"},{"key":"1756_CR9","doi-asserted-by":"crossref","unstructured":"Navarro G, Borroto-Escuela D, Angelats E, Etayo \u00cd, Reyes-Resina I, Pulido-Salgado M, et al. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer\u2019s disease and levodopa-induced dyskinesia. Brain Behav Immun. 2018;67:139\u201351.","DOI":"10.1016\/j.bbi.2017.08.015"},{"key":"1756_CR10","doi-asserted-by":"publisher","unstructured":"Caba\u00f1ero D, Mart\u00edn-Garc\u00eda E, Maldonado R. The CB2 cannabinoid receptor as a therapeutic target in the central nervous system. Expert Opin Ther Targets. 2021;25(8):659\u201376. Available from: https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.1080\/14728222.2021.1971196.","DOI":"10.1080\/14728222.2021.1971196"},{"key":"1756_CR11","doi-asserted-by":"crossref","unstructured":"Bietar B, Tanner S, Lehmann C. Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery. Int J Mol Sci. 2023;24(23):16728. Available from: https:\/\/www.mdpi.com\/1422-0067\/24\/23\/16728.","DOI":"10.3390\/ijms242316728"},{"key":"1756_CR12","doi-asserted-by":"publisher","unstructured":"Bedse G, Romano A, Cianci S, Lavecchia AM, Lorenzo P, Elphick MR, et al. Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer\u2019s Disease. J Alzheimer\u2019s Dis. 2014;40(3):701\u201312. Available from: https:\/\/journals.sagepub.com\/doi\/full\/https:\/\/doi.org\/10.3233\/JAD-131910.","DOI":"10.3233\/JAD-131910"},{"key":"1756_CR13","doi-asserted-by":"publisher","unstructured":"Liu Y, Xing H, Zhang Y, Song Y. The Endocannabinoid System in Alzheimer\u2019s Disease: A Network Meta\u2010Analysis. J Neurosci Res. 2024;102(9). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/jnr.25380.","DOI":"10.1002\/jnr.25380"},{"issue":"12","key":"1756_CR14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1039\/C6NP00074F","volume":"33","author":"LO Hanu\u0161","year":"2016","unstructured":"Hanu\u0161 LO, Meyer SM, Mu\u00f1oz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016;33(12):1357\u201392.","journal-title":"Nat Prod Rep"},{"issue":"5","key":"1756_CR15","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","volume":"2","author":"R Chen","year":"2012","unstructured":"Chen R, Zhang J, Wu Y, Wang D, Feng G, Tang YP, et al. Monoacylglycerol Lipase Is a Therapeutic Target for Alzheimer\u2019s Disease. Cell Rep. 2012;2(5):1329\u201339.","journal-title":"Cell Rep"},{"issue":"16","key":"1756_CR16","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1111\/bph.13186","volume":"172","author":"JA Prenderville","year":"2015","unstructured":"Prenderville JA, Kelly \u00c1M, Downer EJ. The role of cannabinoids in adult neurogenesis. Br J Pharmacol. 2015;172(16):3950\u201363.","journal-title":"Br J Pharmacol"},{"issue":"20","key":"1756_CR17","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie RB, Bagher AM, Kelly MEM, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790\u2013805.","journal-title":"Br J Pharmacol"},{"key":"1756_CR18","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Pinilla E, Varani K, Reyes-Resina I, Angelats E, Vincenzi F, Ferreiro-Vera C, et al. Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors. Front Pharmacol. 20173;8. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00744\/full.","DOI":"10.3389\/fphar.2017.00744"},{"key":"1756_CR19","doi-asserted-by":"crossref","unstructured":"Navarro G, Reyes-Resina I, Rivas-Santisteban R, S\u00e1nchez de Medina V, Morales P, Casano S, et al. Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes. Biochem Pharmacol. 2018;157:148\u201358. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218303824.","DOI":"10.1016\/j.bcp.2018.08.046"},{"issue":"1","key":"1756_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","volume":"89","author":"T Iuvone","year":"2004","unstructured":"Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo AA. Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem. 2004;89(1):134\u201341.","journal-title":"J Neurochem"},{"issue":"1","key":"1756_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox9010021","volume":"9","author":"S Atalay","year":"2019","unstructured":"Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants. 2019;9(1):21.","journal-title":"Antioxidants"},{"issue":"1","key":"1756_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/0269881110379283","volume":"25","author":"JAS Crippa","year":"2011","unstructured":"Crippa JAS, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol. 2011;25(1):121\u201330.","journal-title":"J Psychopharmacol"},{"key":"1756_CR23","doi-asserted-by":"publisher","unstructured":"Crippa JA, Guimar\u00e3es FS, Campos AC, Zuardi AW. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. Front Immunol. 2018;9:2009. https:\/\/doi.org\/10.3389\/fimmu.2018.02009.","DOI":"10.3389\/fimmu.2018.02009"},{"key":"1756_CR24","doi-asserted-by":"publisher","unstructured":"Watt G, Karl T. In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease. Front Pharmacol. 2017;8:20. https:\/\/doi.org\/10.3389\/fphar.2017.00020.","DOI":"10.3389\/fphar.2017.00020"},{"issue":"34","key":"1756_CR25","doi-asserted-by":"publisher","first-page":"55840","DOI":"10.18632\/oncotarget.10095","volume":"7","author":"M Rodr\u00edguez-Mu\u00f1oz","year":"2016","unstructured":"Rodr\u00edguez-Mu\u00f1oz M, S\u00e1nchez-Bl\u00e1zquez P, Merlos M, Garz\u00f3n-Ni\u00f1o J. Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. Oncotarget. 2016;7(34):55840\u201362.","journal-title":"Oncotarget"},{"issue":"8","key":"1756_CR26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","volume":"30","author":"EB Russo","year":"2005","unstructured":"Russo EB, Burnett A, Hall B, Parker KK. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res. 2005;30(8):1037\u201343.","journal-title":"Neurochem Res"},{"issue":"4","key":"1756_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","volume":"15","author":"H Jahn","year":"2013","unstructured":"Jahn H. Memory loss in Alzheimer\u2019s disease. Dialogues Clin Neurosci. 2013;15(4):445\u201354.","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"1756_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2012;8(1):1\u201313.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1756_CR29","doi-asserted-by":"crossref","unstructured":"Alali S, Riazi G, Ashrafi-Kooshk MR, Meknatkhah S, Ahmadian S, Hooshyari Ardakani M, et al. Cannabidiol Inhibits Tau Aggregation In Vitro. Cells. 2021;10(12):3521. Available from: https:\/\/www.mdpi.com\/2073-4409\/10\/12\/3521.","DOI":"10.3390\/cells10123521"},{"key":"1756_CR30","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomedicine. 2019;14:5541\u201354.","journal-title":"Int J Nanomedicine"},{"key":"1756_CR31","doi-asserted-by":"crossref","unstructured":"Al-Qahtani AA, Alhamlan FS, Al-Qahtani AA. Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review. Trop Med Infect Dis. 2024;9(1):13. Available from: https:\/\/www.mdpi.com\/2414-6366\/9\/1\/13.","DOI":"10.3390\/tropicalmed9010013"},{"issue":"2","key":"1756_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/157015907780866884","volume":"5","author":"J Ashton","year":"2007","unstructured":"Ashton J, Glass M. The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration. Curr Neuropharmacol. 2007;5(2):73\u201380.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"1756_CR33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-141014","volume":"43","author":"E Aso","year":"2014","unstructured":"Aso E, S\u00e1nchez-Pla A, Vegas-Lozano E, Maldonado R, Ferrer I. Cannabis-Based Medicine Reduces Multiple Pathological Processes in A\u03b2PP\/PS1 Mice. J Alzheimer\u2019s Dis. 2014;43(3):977\u201391.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"6","key":"1756_CR34","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","volume":"79","author":"AM Mart\u00edn-Moreno","year":"2011","unstructured":"Mart\u00edn-Moreno AM, Reigada D, Ram\u00edrez BG, Mechoulam R, Innamorato N, Cuadrado A, et al. Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer\u2019s Disease. Mol Pharmacol. 2011;79(6):964\u201373.","journal-title":"Mol Pharmacol"},{"key":"1756_CR35","doi-asserted-by":"crossref","unstructured":"Medina-Vera D, Tambaro S. Role of anandamide in Alzheimer\u2019s disease. In: Anandamide in Health and Disease. Elsevier; 2025. p. 419\u201343. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780443190810000147.","DOI":"10.1016\/B978-0-443-19081-0.00014-7"},{"key":"1756_CR36","doi-asserted-by":"publisher","unstructured":"Pan SD, Grandgirard D, Leib SL. Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis. Front Cell Infect Microbiol. 2020;10:588195. https:\/\/doi.org\/10.3389\/fcimb.2020.588195.","DOI":"10.3389\/fcimb.2020.588195"},{"key":"1756_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3389\/fphar.2018.00632","volume":"9","author":"G Navarro","year":"2018","unstructured":"Navarro G, Varani K, Reyes-Resina I, de Medina VS, Rivas-Santisteban R, Callado CSC, et al. Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes. Front Pharmacol. 2018;9:632.","journal-title":"Front Pharmacol"},{"key":"1756_CR38","doi-asserted-by":"crossref","unstructured":"Rivas-Santisteban R, Lillo A, Lillo J, Rebassa JB, Contest\u00ed JS, Saura CA, et al. N-Methyl-D-aspartate (NMDA) and cannabinoid CB2 receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors. Alzheimers Res Ther. 2021;13(1):184. Available from: https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00920-6.","DOI":"10.1186\/s13195-021-00920-6"},{"key":"1756_CR39","doi-asserted-by":"crossref","unstructured":"Neddens J, Daurer M, Flunkert S, Beutl K, Loeffler T, Walker L, et al. Correlation of pyroglutamate amyloid \u03b2 and ptau Ser202\/Thr205 levels in Alzheimer\u2019s disease and related murine models. Ginsberg SD, editor. PLoS One. 2020;15(7):e0235543.","DOI":"10.1371\/journal.pone.0235543"},{"issue":"3","key":"1756_CR40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-130050","volume":"35","author":"MJ Casarejos","year":"2013","unstructured":"Casarejos MJ, Perucho J, Gomez A, Mu\u00f1oz MP, Fernandez-Estevez M, Sagredo O, et al. Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy. J Alzheimer\u2019s Dis. 2013;35(3):525\u201339.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"1756_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neulet.2006.06.012","volume":"404","author":"G Esposito","year":"2006","unstructured":"Esposito G, De Filippis D, Steardo L, Scuderi C, Savani C, Cuomo V, et al. CB1 receptor selective activation inhibits \u03b2-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons. Neurosci Lett. 2006;404(3):342\u20136.","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"1756_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","volume":"399","author":"G Esposito","year":"2006","unstructured":"Esposito G, De Filippis D, Maiuri MC, De Stefano D, Carnuccio R, Iuvone T. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in \u03b2-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-\u03baB involvement. Neurosci Lett. 2006;399(1\u20132):91\u20135.","journal-title":"Neurosci Lett"},{"issue":"14","key":"1756_CR43","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","volume":"95","author":"AJ Hampson","year":"1998","unstructured":"Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (\u2212)\u0394 9 -tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci. 1998;95(14):8268\u201373.","journal-title":"Proc Natl Acad Sci"},{"key":"1756_CR44","doi-asserted-by":"crossref","unstructured":"Salgado K del CB, Nascimento RG de F, Coelho PJFN, Oliveira LAM, Nogueira KOPC. Cannabidiol protects mouse hippocampal neurons from neurotoxicity induced by amyloid \u03b2-peptide25\u201335. Toxicol Vitr. 2024;99:105880.","DOI":"10.1016\/j.tiv.2024.105880"},{"key":"1756_CR45","doi-asserted-by":"publisher","first-page":"118624","DOI":"10.1016\/j.lfs.2020.118624","volume":"264","author":"F Hao","year":"2021","unstructured":"Hao F, Feng Y. Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP\/PS1 Alzheimer\u2019s mice uncovered by RNA-seq. Life Sci. 2021;264:118624.","journal-title":"Life Sci"},{"key":"1756_CR46","doi-asserted-by":"publisher","unstructured":"Strisciuglio C, Creoli M, Tortora C, Martinelli M, Miele E, Paino S, Luongo L, Rossi F. Increased expression of CB2 receptor in the intestinal biopsies of children with inflammatory bowel disease. Pediatr Res. 2023;93(3):520\u20135. https:\/\/doi.org\/10.1038\/s41390-022-02109-5.","DOI":"10.1038\/s41390-022-02109-5"},{"issue":"2","key":"1756_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/1570159X16666180702144644","volume":"17","author":"G Talarico","year":"2019","unstructured":"Talarico G, Trebbastoni A, Bruno G, de Lena C. Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer\u2019s Disease. Curr Neuropharmacol. 2019;17(2):176\u201383.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"1756_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/ijms18010026","volume":"18","author":"R Libro","year":"2016","unstructured":"Libro R, Diomede F, Scionti D, Piattelli A, Grassi G, Pollastro F, et al. Cannabidiol Modulates the Expression of Alzheimer\u2019s Disease-Related Genes in Mesenchymal Stem Cells. Int J Mol Sci. 2016;18(1):26.","journal-title":"Int J Mol Sci"},{"key":"1756_CR49","doi-asserted-by":"crossref","unstructured":"Vivanco-Estela AN, Dos-Santos-Pereira M, Guimaraes FS, Del-Bel E, Nascimento GC d. Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats. Neuropharmacology. 2021;196:108700.","DOI":"10.1016\/j.neuropharm.2021.108700"},{"issue":"4","key":"1756_CR50","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3233\/JAD-140921","volume":"42","author":"D Cheng","year":"2014","unstructured":"Cheng D, Spiro AS, Jenner AM, Garner B, Karl T. Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer\u2019s Disease Transgenic Mice. J Alzheimer\u2019s Dis. 2014;42(4):1383\u201396.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1756_CR51","doi-asserted-by":"publisher","unstructured":"Defrancesco M, Hofer A. Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer's Dementia: A Clinical Case Report. Front Psychiatry. 2020;11:413. https:\/\/doi.org\/10.3389\/fpsyt.2020.00413.","DOI":"10.3389\/fpsyt.2020.00413"},{"issue":"6","key":"1756_CR52","first-page":"542","volume":"10","author":"G Abate","year":"2021","unstructured":"Abate G, Uberti D, Tambaro S. Potential and Limits of Cannabinoids in Alzheimer\u2019s Disease Therapy. Biology (Basel). 2021;10(6):542.","journal-title":"Biology (Basel)"},{"issue":"1","key":"1756_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","volume":"207","author":"JI Lemos","year":"2010","unstructured":"Lemos JI, Resstel LB, Guimar\u00e3es FS. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behav Brain Res. 2010;207(1):105\u201311.","journal-title":"Behav Brain Res"},{"key":"1756_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2022.113812","volume":"425","author":"F Kreilaus","year":"2022","unstructured":"Kreilaus F, Przybyla M, Ittner L, Karl T. Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58\/2 transgenic mice. Behav Brain Res. 2022;425:113812.","journal-title":"Behav Brain Res"},{"key":"1756_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.172970","volume":"196","author":"G Watt","year":"2020","unstructured":"Watt G, Chesworth R, Przybyla M, Ittner A, Garner B, Ittner LM, et al. Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58\/2 transgenic mice. Pharmacol Biochem Behav. 2020;196:172970.","journal-title":"Pharmacol Biochem Behav"},{"key":"1756_CR56","doi-asserted-by":"crossref","unstructured":"Chen SW, Cremades N. Preparation of \u03b1-Synuclein Amyloid Assemblies for Toxicity Experiments. In 2018. p. 45\u201360.","DOI":"10.1007\/978-1-4939-7816-8_4"},{"key":"1756_CR57","doi-asserted-by":"crossref","unstructured":"Tarutani A, Suzuki G, Shimozawa A, Nonaka T, Akiyama H, Hisanaga S ichi, et al. The Effect of Fragmented Pathogenic \u03b1-Synuclein Seeds on Prion-like Propagation. J Biol Chem. 2016;291(36):18675\u201388.","DOI":"10.1074\/jbc.M116.734707"},{"issue":"42","key":"1756_CR58","doi-asserted-by":"publisher","first-page":"36762","DOI":"10.1074\/jbc.M111.280339","volume":"286","author":"J Hradsky","year":"2011","unstructured":"Hradsky J, Raghuram V, Reddy PP, Navarro G, Hupe M, Casado V, et al. Post-translational membrane insertion of tail-anchored transmembrane EF-hand Ca2+sensor calneurons requires the TRC40\/Asna1 protein chaperone. J Biol Chem. 2011;286(42):36762\u201376.","journal-title":"J Biol Chem"},{"key":"1756_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fcell.2018.00067","volume":"6","author":"E Angelats","year":"2018","unstructured":"Angelats E, Requesens M, Aguinaga D, Kreutz MR, Franco R, Navarro G. Neuronal Calcium and cAMP Cross-Talk Mediated by Cannabinoid CB1 Receptor and EF-Hand Calcium Sensor Interactions. Front Cell Dev Biol. 2018;6:67. https:\/\/doi.org\/10.3389\/fcell.2018.00067.","journal-title":"Front Cell Dev Biol."},{"key":"1756_CR60","doi-asserted-by":"crossref","unstructured":"Masuda-Suzukake M, Nonaka T, Hosokawa M, Kubo M, Shimozawa A, Akiyama H, et al. Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun. 2014;2(1):88. Available from: https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-014-0088-8.","DOI":"10.1186\/PREACCEPT-1296467154135944"},{"key":"1756_CR61","doi-asserted-by":"crossref","unstructured":"Bellver\u2010Sanchis A, Singh Choudhary B, Companys\u2010Alemany J, Sukanya, \u00c1vila\u2010L\u00f3pez PA, Mart\u00ednez Rodr\u00edguez AL, et al. Structure\u2010Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti\u2010Alzheimer\u2019s Agents. ChemMedChem. 2022;17(13). Available from: https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/10.1002\/cmdc.202200002.","DOI":"10.1002\/cmdc.202200002"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01756-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01756-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:36:38Z","timestamp":1747719398000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01756-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1756"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01756-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal handling, sacrifice, and further experiments were conducted according to the guidelines set in Directive 2010\/63\/EU of the European Parliament and the Council of the European Union that is enforced in Spain by National and Regional organisms; the 3R rule (replace, refine, reduce) for animal experimentation was also taken into account. By the current legislation, protocol approval is not needed if animals are sacrificed to obtain a specific tissue. All animal experiments have been conducted according to ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}